13F-HR filed by MPM BIOIMPACT LLC
MPM BIOIMPACT LLC filed this 13F-HR for the quarter ended 2022-03-31, filed 2022-05-13, with 37 holding rows worth $372,613,000.
- Accession
- 0000950123-22-005661
- Filer
- CIK 1687078
- Filed
- 2022-05-13
- Accepted by EDGAR
- acceptance time not in the bulk data set
- Ingested
- Source
- SEC quarterly data set
13F report for Q1 2022
A holdings report, 37 entries on the cover page, a total value of $372,613,000 stated on the cover page (in dollars after the unit check, H1), rows summing to $372,610,000 with VALUE read as thousands by filing date, 13F file number 028-20107. The quarter's positions are built on this report. The resolved quarter.
The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).
| Issuer as filed | CUSIP | Class | Amount | Value | Value read as | Type |
|---|---|---|---|---|---|---|
| CULLINAN THERAPEUTICS INC | 230031106 | COM | 7,648,268 | $80,077,000 | thousands by filing date | |
| ITEOS THERAPEUTICS INC | 46565G104 | COM | 1,745,943 | $56,184,000 | thousands by filing date | |
| MERUS N V | N5749R100 | COM | 919,482 | $24,311,000 | thousands by filing date | |
| REPARE THERAPEUTICS INC | 760273102 | COM | 1,639,849 | $23,351,000 | thousands by filing date | |
| HARPOON THERAPEUTICS INC | 41358P106 | COM | 3,196,707 | $15,888,000 | thousands by filing date | |
| INTELLIA THERAPEUTICS INC | 45826J105 | COM | 159,409 | $11,584,000 | thousands by filing date | |
| WEREWOLF THERAPEUTICS INC | 95075A107 | CMN | 2,388,011 | $10,507,000 | thousands by filing date | |
| BIOCRYST PHARMACEUTICALS INC COM | 09058V103 | Stock | 639,089 | $10,392,000 | thousands by filing date | |
| TURNING PT THERAPEUTICS | 90041T108 | COM | 351,350 | $9,434,000 | thousands by filing date | |
| TCR2 THERAPEUTICS INC | 87808K106 | COM | 3,370,982 | $9,304,000 | thousands by filing date | |
| GERON CORP | 374163103 | COM | 6,149,277 | $8,363,000 | thousands by filing date | |
| CYTOKINETICS INC | 23282W605 | COM NEW | 224,246 | $8,254,000 | thousands by filing date | |
| CRINETICS PHARMACEUTICALS INC COM | 22663K107 | Stock | 366,676 | $8,049,000 | thousands by filing date | |
| TRAVERE THERAPEUTICS INC | 89422G107 | COM | 277,950 | $7,163,000 | thousands by filing date | |
| HARMONY BIOSCIENCES HLDGS IN | 413197104 | COM | 137,517 | $6,690,000 | thousands by filing date | |
| G1 THERAPEUTICS INC | 3621LQ109 | COM | 856,798 | $6,512,000 | thousands by filing date | |
| MIRUM PHARMACEUTICALS INC | 604749101 | COM | 288,531 | $6,353,000 | thousands by filing date | |
| REATA PHARMACEUTICALS INC | 75615P103 | CL A | 180,000 | $5,897,000 | thousands by filing date | |
| Y-mAbs Therapeutics Inc | 984241109 | Common Stock | 443,702 | $5,271,000 | thousands by filing date | |
| ARCUTIS BIOTHERAPEUTICS INC | 03969K108 | COM | 258,500 | $4,979,000 | thousands by filing date | |
| ADC THERAPEUTICS SA | H0036K147 | COMMON STOCK | 334,384 | $4,912,000 | thousands by filing date | |
| AMICUS THERAPEUTICS INC | 03152W109 | COM | 495,603 | $4,693,000 | thousands by filing date | |
| VERASTEM INC | 92337C104 | COM | 3,244,650 | $4,575,000 | thousands by filing date | |
| ONCORUS INC | 68236R103 | COM | 2,377,031 | $4,231,000 | thousands by filing date | |
| AXSOME THERAPEUTICS INC. COM | 05464T104 | Stock | 99,834 | $4,132,000 | thousands by filing date | |
| ESSA PHARMA INC | 29668H708 | COM NEW | 660,892 | $4,084,000 | thousands by filing date | |
| EPIZYME INC | 29428V104 | COM | 3,425,202 | $3,939,000 | thousands by filing date | |
| REVOLUTION MEDICINES INC COM | 76155X100 | Stock | 146,041 | $3,726,000 | thousands by filing date | |
| RELMADA THERAPEUTICS INC | 75955J402 | COMMON STOCK | 138,000 | $3,725,000 | thousands by filing date | |
| ACADIA PHARMACEUTICALS INC | 004225108 | COM | 151,750 | $3,675,000 | thousands by filing date | |
| AVADEL PHARMACEUTICALS, PLC | 05337M104 | COMMON STOCK-FO | 412,363 | $2,816,000 | thousands by filing date | |
| PHATHOM PHARMACEUTICALS INC | 71722W107 | COMMON STOCK | 193,326 | $2,631,000 | thousands by filing date | |
| KARUNA THERAPEUTICS INC | 48576A100 | COM | 20,000 | $2,536,000 | thousands by filing date | |
| NEOGENOMICS INC | 64049M209 | COM NEW | 135,573 | $1,647,000 | thousands by filing date | |
| INOZYME PHARMA INC | 45790W108 | COM | 294,980 | $1,206,000 | thousands by filing date | |
| TECTONIC THERAPEUTIC INC COM | 05455M100 | Stock | 647,918 | $855,000 | thousands by filing date | |
| BLACK DIAMOND THERAPEUTICS I | 09203E105 | COM | 239,888 | $664,000 | thousands by filing date |
Amendment chain
| Filing | Role | Filed | Accepted | Ingested |
|---|---|---|---|---|
| 13F-HR 0000950123-22-005661 | this filing | 2022-05-13 | acceptance time not in the bulk data set |